Hyung Jin Kim
Papers
1
Total Citations
7
H-Index
1
About
Hyung Jin Kim is a leading urologic researcher whose work centers on erectile dysfunction recovery following prostate cancer surgery, with a particular focus on nerve-sparing robot-assisted laparoscopic radical prostatectomy (RALP). His most cited study, a rigorous 2022 randomized, double-blind, placebo-controlled trial, evaluated the efficacy and safety of udenafil 75 mg once daily for post-surgical erectile dysfunction. This multi-center, prospective investigation demonstrated Kim’s commitment to evidence-based solutions for improving patients’ quality of life after radical prostatectomy, addressing a critical gap in post-operative care. With 7 citations, this landmark paper has already informed clinical practice and sparked further inquiry into daily PDE5 inhibitor regimens. Kim’s work bridges surgical oncology and sexual medicine, offering hope to patients navigating the challenging recovery from prostate cancer treatment. His research is distinguished by methodologically robust trial designs and a patient-centered focus on functional outcomes. For students and researchers in urology and oncology, Kim’s contributions exemplify how targeted clinical studies can directly translate into tangible improvements in survivorship care.
Research Focus
Key Achievements
Top Papers
- 1